4-(4-联苯基)-2,4-二氧代丁酸 | 85763-16-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-(4-联苯基)-2,4-二氧代丁酸
• 英文名称: 4-((1,1'-biphenyl)-4-yl)-2,4-dioxobutanoic acid
• 英文别名: 4-([1,1'-biphenyl]-4-yl)-2,4-dioxobutanoic acid；4-[(1,1'-biphenyl)-4-yl]-2,4-dioxo-1-butanoic acid；2,4-dioxo-4-(4-phenylphenyl)butanoic acid
• CAS: 85763-16-2
• 化学式: C₁₆H₁₂O₄
• 分子量: 268.269
• InChiKey: OCTADEKBEAHCGJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  71.4
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2918300090

反应信息

• 作为反应物：
  描述：

  4-(4-联苯基)-2,4-二氧代丁酸 在 一水合肼 、 溶剂黄146 作用下， 以85%的产率得到5-联苯-4-基-1H-吡唑-3-羧酸
  参考文献：
  名称：

  5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII

  摘要：

  Inhibitory activity of a congeneric set of 23 phenyl-substituted 5-phenyl-pyrazole-3-carboxylic acids toward human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms I, II, IX and XII was evaluated by a stopped-flow CO2 hydrase assay. These compounds exerted a clear, selective inhibition of hCA IX and XII over hCAI and II, with Ki in two to one digit micromolar concentrations (4-50 mu M). Derivatives bearing bulkier substituents in para-position of the phenyl ring inhibited hCA XII at one-digit micromolar concentrations, while derivatives having alkyl substituents in both ortho-and meta-positions inhibited hCA IX with Kis ranging between 5 and 25 mu M. Results of docking experiments offered a rational explanation on the selectivity of these compounds toward CA IX and XII, as well as on the substitution patterns leading to best CA IX or CA XII inhibitors. By examining the active sites of these four isoforms with GRID generated molecular-interaction fields, striking differences between hCA XII and the other three isoforms were observed. The field of hydrophobic probe (DRY) appeared significantly different in CA XII active site, comparing to other three isoforms studied. To the best of our knowledge such an observation was not reported in literature so far. Considering the selectivity of these carboxylates towards membrane-associated over cytosolic CA isoforms, the title compounds could be useful for the development of isoform-specific non-sulfonamide CA inhibitors. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.05.052
• 作为产物：
  描述：

  联苯单乙酮 在 sodium hydroxide 、 sodium methylate 作用下， 以 1,4-二氧六环 、 乙醇 、 苯 为溶剂， 反应 2.5h， 生成 4-(4-联苯基)-2,4-二氧代丁酸
  参考文献：
  名称：

  Inhibitors of glycolic acid oxidase. 4-Substituted-2,4-dioxobutanoic acid derivatives

  摘要：

  Fourteen new 4-substituted 2,4-dioxobutanoic acids have been synthesized. These compounds, all of which contain lipophilic 4-substituents, are potent inhibitors in vitro of porcine liver glycolic acid oxidase. The I50 value of the two most potent representatives, 4-(4'-bromo[1,1'-biphenyl]-4-yl)-2, 4-dioxobutanoic acid (8) and 4-[4'-[[(3,4-dihydro-3-hydroxy-2H-1, 5-benzodioxepin-3-yl)methyl]thio][1,1'-biphenyl]-4-yl]-2, 4-dioxobutanoic acid (13) is 6 X 10(-8)M.

  DOI：

  10.1021/jm00362a020

文献信息

• Synthesis, antimicrobial activity, structure-activity relationship and cytotoxic studies of a new series of functionalized (Z)-3-(2-oxo-2-substituted ethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ones
  作者：Ritu Sharma、Lalit Yadav、Jaggi Lal、Pradeep K. Jaiswal、Manas Mathur、Ajit K. Swami、Sandeep Chaudhary

  DOI：10.1016/j.bmcl.2017.08.017

  日期：2017.9

  ethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ones 23–26, incorporating pharmaceutically privileged substructures such as cyclopropyl, naphthyl, biphenyl and cyclohexylphenyl were synthesized in excellent yields. All the synthesized compounds were screened for their in vitro antibacterial activity against gram-(+)ve and gram-(−)ve bacterial species i.e. S. griseus, S. aureus, B. subtillis and E. coli as

  一系列新的官能化（Z）-3-（2-氧-2-取代亚乙基）-3,4-二氢-2 H-苯并[ b ] [1,4]恶嗪-2-酮23 – 26，以优异的产率合成了药学上优先的亚结构，例如环丙基，萘基，联苯和环己基苯基。所有合成的化合物筛选它们体外抗革兰氏抗菌活性- （+）ve和克- （ - ）已经细菌物种即灰色链霉菌，金黄色葡萄球菌，枯草芽孢杆菌和大肠杆菌以及体外抗真菌对真菌物种，即氧化枯萎病菌的活性，A。niger，P。funiculosum和T. reesei。在这项研究中，与标准药物，氨苄青霉素和氯霉素以及酮康唑相比，含有环丙基和环己基苯基亚结构的化合物被确定为有前途的抗菌剂。SAR研究表明，吸电子基团增加了2-氧代-苯并[1,4]恶嗪的抗菌和抗真菌活性，反之亦然。该系列中活性最高的化合物23e和26e比氨苄青霉素和氯霉素显示出令人鼓舞的抗菌活性。此外，化合物26d与酮康唑相比，它显示出有希望的抗真菌效力。使用MTT分析法对3T
• [EN] HIV INTEGRASE INHIBITORS<br/>[FR] INHIBITEURS DE VIH INTEGRASE
  申请人：MERCK & CO., INC.

  公开号：WO1999062520A1

  公开（公告）日：1999-12-09

  (EN) Certain six-membered aromatic and heteroaromatic-dioxo-butyric acid derivatives are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.(FR) Cette invention a trait à certains dérivés d'acide dioxo-butyrique à 6 chaînons, aromatique et hétéro-aromatique, agissant en tant qu'inhibiteurs de VIH intégrase et de la réplication du VIH. Ces composés sont utilisés dans le cadre de la prévention et du traitement des infections par le VIH et du sida, que ce soit sous forme de composés, de sels acceptables du point de vue pharmaceutique ou d'ingrédients de composition pharmaceutique, seuls ou associés à d'autres antiviraux, immunorégulateurs, antibiotiques ou vaccins. L'invention concerne également des méthodes de traitement du sida ainsi que des méthodes de prévention et de traitement des infections par VIH.

  某些六元芳香和杂芳二酮丁酸衍生物被描述为HIV整合酶抑制剂和HIV复制抑制剂。这些化合物可用于预防或治疗HIV感染和治疗艾滋病，无论是作为化合物、药学上可接受的盐、药物组成成分，还是与其他抗病毒药物、免疫调节剂、抗生素或疫苗联合使用。还描述了治疗艾滋病的方法以及预防或治疗HIV感染的方法。
• The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors
  作者：L. Nathan Tumey、Bayard Huck、Elizabeth Gleason、Jianmin Wang、Daniel Silver、Kurt Brunden、Sherry Boozer、Stephen Rundlett、Bruce Sherf、Steven Murphy、Andrew Bailey、Tom Dent、Christina Leventhal、John Harrington、Youssef L. Bennani

  DOI：10.1016/j.bmcl.2004.07.028

  日期：2004.10

  There have been several recent reports of chemopotentiation via inhibition of DNA repair processes. Flap endonuclease 1 (FEN1) is a key enzyme involved in base excision repair (BER), a primary pathway utilized by mammalian cells to repair DNA damage. In this report, we describe the identification and SAR of a series of 2,4-diketobutyric acid FENI inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.
• EP1082121A4
  申请人：——

  公开号：EP1082121A4

  公开（公告）日：2003-02-05
• HIV INTEGRASE INHIBITORS
  申请人：MERCK & CO., INC.

  公开号：EP1082121A1

  公开（公告）日：2001-03-14